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A RANDOMIZED STUDY OF 
THE INFLUENCE OF 
PERFUSION TECHNIQUE 
AND PH MANAGEMENT 
STRATEGY IN 316 PATIENTS 
UNDERGOING CORONARY 
ARTERY BYPASS SURGERY 
II. Neurologic and 
cognitive outcomes 
This double-blind, randomized comparison f pulsatile or nonpulsatile perfu- 
sion and alpha-stat or pH-stat management during cardiopulmonary bypass 
was designed to assess postoperative central nervous system outcomes. Meth- 
ods: Neurologic and cognitive testing was conducted before the operation and 
7 days and 2 months after the operation in 316 patients having coronary artery 
bypass and in a reference cohort of 40 patients having major vascular and 
thoracic operations. Results: As detailed in part I of this study, mortality in 
patients having coronary bypass was 2.8%. The incidence of stroke was 2.5% 
and did not differ among bypass groups. Mortality was 2.5% for the major 
surgery cohort. The incidence of cognitive (p = 0.003) and either neurologic or 
cognitive dysfunction (p = 0.0002) was higher at 7 days for the coronary bypass 
group than for the major surgery cohort. The incidence of neurologic dysfunc- 
tion remained higher (p = 0.050) at 2 months in the coronary bypass group. 
Cognitive dysfunction at 2 months was less prevalent after 90 minutes of 
cardiopulmonary bypass in patients managed with alpha-stat than with 
pH-stat strategy (27% versus 44%, p = 0.047). Conclusions: Postoperative 
central nervous system dysfunction is more prevalent in patients having 
coronary bypass than in those having major operations. Pulsatility has no 
effect on central nervous ystem outcomes, but alpha-stat management is 
associated with a decreased incidence of cognitive dysfunction in patients 
undergoing prolonged cardiopulmonary bypass. (J THORAC CARDIOVASC SURG 
1995;110:349-62) 
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have been increasing significantly over the past 
decade? In an assessment of more than 2000 pa- 
tients undergoing CAB operations, advanced age 
was the greatest risk factor for postoperative neuro- 
logic dysfunction. 2 In addition to age, studies have 
demonstrated that longer duration of cardiopulmo- 
nary bypass (CPB) also increases the risk of postop- 
erative cognitive dysfunction. 3-5 Increasingly, pa- 
tient deaths have been attributed to postoperative 
neurologic injury. From 1970 to 1973, 8% of pa- 
tients with CAB died after an adverse neurologic 
event; by contrast, from 1980 to 1983, 20% of 
postoperative deaths were attributable to neurologic 
injury. 6 
At the same time a high incidence of subtle 
neurobehavioral dysfunction has been identified. 
Overall, the incidence of cognitive dysfunction after 
CAB operations has been demonstrated to range 
from 24% to 79% in the postoperative period 3' 4, v, 8 
and averages 35% at post-discharge follow-up, 4' 9 
with 35% of patients still having cognitive impair- 
ment 12 months after the operation. 5 
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Previous studies have demonstrated the influence 
of pH management s rategy 1°-12 and perfusion tech- 
nique13, 14 on cerebral blood flow during CPB. How- 
ever, relatively few studies have assessed their 
impact on postoperative patient outcomesJ  5-1s Ac- 
cordingly, the current study was designed to deter- 
mine the influence of alpha-stat or pH-stat pH 
management and pulsatile or nonpulsatile perfusion 
during CPB on postoperative neurologic and cogni- 
tive functioning in a group of patients undergoing 
CAB surgery. 
In addition, to better define the role of exposure 
to CPB in the genesis of postoperative central 
nervous system (CNS) dysfunction, a reference co- 
hort of  patients undergoing major thoracic or ab- 
dominal aortic procedures, but not cardiac operations, 
termed the noncardiac surgical cohort, underwent 
identical cognitive and neurologic examinations at 
similar intervals. 
Methods 
Study objective. This is part II of a two-part study, part 
I appearing elsewhere in this JOURNAL. 19 The primary 
objective of this double-blind, randomized, clinical trial 
was to compare the impact of different pH management 
strategies and perfusion techniques during CPB on the 
incidence of cognitive and neurologic dysfunction in pa- 
tients after CAB surgery. Secondarily, these results were 
compared with the incidences of CNS dysfunction in a 
group of patients undergoing major noncardiac opera- 
tions. Study group characteristics, protocol-related inclu- 
sion and exclusion criteria, and details of pH management 
and perfusion technique during CPB are described in part 
I . 19 
Reference cohort. To more clearly identify the risk of 
postoperative dysfunction as related to CPB--indepen- 
dent of undergoing a major surgical procedure--a non- 
cardiac surgical cohort of 40 patients undergoing either 
abdominal aortic surgery (n = 27) or thoracic surgery 
(n = 13) undelwent the same standardized preoperative 
and postoperative neurologic and cognitive assessments. 
Neurologic assessment. A standardized neurologic ex- 
amination assessing mentation, cranial nerve function, 
motor power, reflexes, sensation/cerebellar function, and 
gait, with 14 individual elements graded on a scale from 0 
to 3 for a possible total of 42 (Table I; see also Appendix 
I for description), was performed within 24 hours after the 
operation, at 7 days after the operation, and at a 2-month 
follow-up visit, by a qualified nurse specialist. A score of 
less than 3 on any of the applicable lements on baseline 
assessment was identified as indicating preoperative neu- 
rologic dysfunction. The criterion for defining postopera- 
tive neurologic dysfunction was a decrease from baseline 
of individual elements totaling 2 or more points, repre- 
senting either mild decrease in performance in two areas 
or significant decrease in one area. 
Neuropsyehologic assessment. A series of cognitive 
tests were administered by a nurse specialist at the same 
times as the neurologic examination under direction of a 
clinical neuropsychologist (J.S.M.). Specific tests used 
were as follows: (1) the Digit Span and Mental Control 
subtests of the Weschler Memory Scale, for which scores 
were standardized and averaged to achieve a composite 
measure of concentration, (2) the Digit Symbol subtest of 
the Weschler Adult Intelligence Scale-Revised (ameasure 
of psychomotor speed); (3) the Grooved Pegboard test, a 
measure of manual dexterity, for which the times for both 
hands were summed; and (4) the Verbal Paired Associates 
subtest of the Wechsler Memory Scale (a measure of 
verbal learning). Alternate forms of the Digit Span, 
Mental Control, and Verbal Paired Associates were used 
and administered in an A-B-A sequence for half the 
patients and a B-A-B sequence for the other half, so as to 
reduce practice effects across assessments. 
Cognitive dysfunction. Failure to show progressive im- 
provement in cognitive test performance over time 
("learning effect") is a highly sensitive marker of minimal 
dysfunction and has been used by Sotaniemi, Mononen, 
and Hokkanen 2° to define late dysfunction after cardiac 
operations. To define postoperative cognitive dysfunction 
and to control for the learning effect, we recruited a 
nonhospitalized group of 41 age and gender matched 
volunteers (a normative control group) to undergo the 
same cognitive battery at similar intervals as the treatment 
groups. Change scores from baseline were computed for 
each cognitive test, and a distribution of change scores was 
compiled for the normative control group to provide a 
range of "normal" variability in change scores that was 
specific for each domain (test) at each point. Cutoffs for 
"abnormal" functioning in the study groups were opera- 
tionally defined as change scores that were exceeded by 
95% (39 members) of the normative control group, m 
Values used as cutoffs for defining abnormal performance 
among the surgically treated patients are presented in 
Table II. Cognitive dysfunction was defined as impaired 
performance within one or more of the four areas as- 
sessed. 
Statistical analysis. The target sample size for this 
study was 304 patients undergoing CAB. The analysis was 
based on an anticipated adverse cognitive outcome rate of 
35%, and a reduction to 20% was considered to represent 
a clinically significant difference. This sample size would 
provide 80% power at the 0.05 a level and allow for a 10% 
dropout rate, to compare alpha-stat versus pH-stat man- 
agement and pulsatile versus nonpulsatile perfusion, pro- 
vided that these two interventions did not interact. 
To standardize the influence of repeated neuropsycho- 
logic testings, we included only results from patients who 
underwent cognitive testing at 7 days in the 2-month 
follow-up analysis. Cognitive testing from patients not 
completing any or all components of the cognitive battery 
were not included in the analyses of cognitive outcomes 
unless their performance on that portion of the testing 
completed was impaired relative to their baseline level of 
performance. 
Log-linear model analysis was first performed to ensure 
that no interaction existed between pH management, 
perfusion technique, and outcome vents. Outcome vents 
were compared between treatment groups by means of the 
9( 2 test. Fisher's two-tailed exact est was used if the expected 
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Table I 
~'estern Perioperative Neurological Scale 
PT# 
NEUROLOGICAL ASSESSMENT SCALE SCORES Enter scores in appropriate ¢o~umn$ 
EXAMINATION 
;NTATION 
/EL OF 
CC NSCIOUSNESS 
EECH 
MOTOR 
ANIAL NERVES 
VISION 
CRANIAL NERVES 
RIGHT ARM 
PREOP 7 DAYS 2 MONTHS 
LEFT ARM 
i i  
RIGHT LEG 
LEFT LEG 
CEREBELLUM~SENSATION 
FLEXES 
RIGHT SIDE SEN. 
LEFT SIDE SEN. 
CEREBELLAR 
FUNCTION 
IMITIVE REFLEXES 
TOTAL 
BASE SCORE 
t i t  
SCALE 
3 -ALERT 
2-DROWSY 
1-STUPOROUS 
0-COMATOSE 
3-NORMAL 
2-DYSPHASIA 
1 -APHASIA 
0-MUTE 
;~NORMAL 
2-MILD DEFICIT 
1-MOD. DEFICIT 
0-SEV. DEFICIT 
&NORMAL 
2-MILD DEFICIT 
1-MOD. DERCIT 
0-SEV. DEFICIT 
3-MORMAL 
2-MILD WEAKNESS 
1-MOD.WEAKNESS 
0-SEV. WEAKNESS 
3-NORMAL 
2-MILD DEFICIT 
1-MOD. DEFICIT 
0-SEV. DEFICIT 
3-NORMAL 
2-MILD DEFICIT 
1-MOD. DEFICIT 
0-SEV. DEFICIT 
~ABSENT 
2-ONE PRESENT 
1-TWO PRESENT 
GALL PRESENT 
3-NORMAL 
2-MILD DEFICIT 
1-MOD. DEFICIT 
0-SEV. DEFICIT 
. . . . .  
Patients are assessed and scored on a scale from 0 to 3 for a total possible 
score of 42, preoperatively, and at 7 days and 2 months postperatively. 
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Table II. Change scores* from baseline used as 
cutoffs to identify impairment in surgically treated 
patients 
Assessment i erval 
At 7days At follow-up? 
Concentration:~ 95% > -1 .14 95% > -1 .2  
Grooved Pegboard time (sec) 95% < 9 95% < 14 
Digit Symbol raw score 95% > 0 95% > -2  
Associate Learning raw score§ 95% > -10  95% > -4  
*For Grooved Pegboard test, higher scores reflect decreased performance 
from baseline; for all other measures, lower scores reflect decreased 
performance from baseline. 
tFollow-up testing was conducted approximately 2 months after baseline 
testing. 
:]:Concentration score = (Mental Control Z-score + Digit Span Z-score)/2. 
§Associate Learning raw score = No. easy correct + 2 (No. hard correct). 
cell sizes were small. Demographic characteristics were 
assessed similarly for categoric variables. Two-way factorial 
analysis of variance was used to examine continuous vari- 
ables and to confirm that pH management did not interact 
with perfusion technique. No adjustments were made for 
multiple comparisons. Logistic regression analysis was 
applied to examine potential risk factors for neurologic 
and cognitive dysfunction. 
Results 
A total of 316 patients undergoing CAB opera- 
tions were enrolled in this study. On average, slightly 
more than two patients were enrolled weekly, con- 
stituting approximately 30% of all patients undergo- 
ing CAB during this period. Demographic and 
clinical characteristics of the 316 patients in the 
study and the 40 patients in the noncardiac surgical 
cohort are shown in Table IH. Other than signifi- 
cantly greater numbers of women in the major 
surgery cohort, there were no other differences in 
identifiable risk factors between patients having 
CAB and the reference cohort. Intended treatments 
during CPB were achieved such that there were 
appropriate and significant differences in arterial pH 
and arterial carbon dioxide tension between pH 
management groups and in pulse pressure between 
the pulsatile and nonpulsatile groups (Table IV). 
Among 316 patients enrolled, there were 9 
(2.85%) in-hospital deaths, 4 occurring in the alpha- 
stat group and 5 in pH-stat group (p = NS*). As 
discussed in detail in part I of this study, 1 death 
occurred in the pulsatile group and 8 in the nonpul- 
satile group (p = 0.018). 19 Four patients in each of 
the alpha-stat and pH-stat groups had a neuroradio- 
logically confirmed cerebrovascular accident (CVA) 
*NS = Not significant. 
(p = NS among all groups), 5 of whom had multiple 
areas of cortical infarction consistent with cerebral 
emboli and 3 of whom subsequently died in the 
hospital. There was 1 in-hospital death from myo- 
cardial infarction in the noncardiac surgical cohort. 
Table V presents ummary statistics for patients 
in the CAB and noncardiac surgical groups on 
measures of neurologic and cognitive functioning at 
baseline and 7 days and 2 months after the opera- 
tion. Classification of patients as exhibiting neuro- 
logic or cognitive impairment resulted in an inci- 
dence of neurologic dysfunction that ranged from 
28% to 33% and cognitive dysfunction that ranged 
from 78% to 80% at 7 days across the four CAB 
treatment groups (p = NS; see Table VI). The 
incidence of any dysfunction (either neurologic or 
cognitive impairment) ranged from 82% to 87% 
(p -- NS). At 2 months' assessment, the incidence of 
neurologic impairment had decreased to 17% to 
18% and the incidence of cognitive impairment had 
decreased to 30% to 36% across the four groups. Of 
the 316 patients enrolled at the time of the 7-day 
assessment, 26 refused or were unavailable for ei- 
ther cognitive or neurologic testing, 15 patients 
underwent neurologic but not cognitive testing, a 
further 2 patients had incomplete cognitive testing, 
and 1 underwent cognitive but not neurologic as- 
sessment. At the 2-month follow-up assessment, 39 
patients were unavailable for any testing, and 1 
underwent cognitive but not neurologic assessment. 
A further 4 patients did not undergo any cognitive 
assessment, 26 were excluded from analysis of cog- 
nitive performance because of the lack of a 7-day 
cognitive assessment, and 8 were excluded from 
analysis for cognitive assessment because of incom- 
plete cognitive testing at follow-up. Surviving pa- 
tients who did not complete 7-day or 2-month 
assessments were similarly distributed among all 
four treatment groups for all circumstances a soci- 
ated with unavailability or exclusion (NS according 
to X 2 test). 
Neurologic and cognitive dysfunction by CAB 
treatment group. For the four CAB treatment 
groups (e.g., alpha-stat/pulsatile, alpha-stat/nonpul- 
satile, pH-stat/pulsatile, pH-stat/nonpulsatile), no
interactions were found between pH management 
strategy, perfusion technique, and dysfunction (neu- 
rologic, cognitive, and either neurologic or cogni- 
tive, at 7 days and at follow-up). When analyzed 
according to either pulsatility or pH management, 
there were no significant differences between pH 
management strategy and perfusion technique. 
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Table III. CAB and noncardiac surgical cohort demographics 
Alpha-stat pH-stat 
Pulsatile Nonpulsatile Pulsatile Nonpulsatile CAB total Surgical cohort 
(n = 79) (n = 79) (n = 79) (n = 79) (n = 316) (n = 40) 
Age (yr) 60.9 -+ 8.7 61.2 _+ 7.8 60.2 .+ 8.5 61.4 _+ 8.4 60.9 _+ 8.3 63.1 ,+ 8.4 
Gender: M/F 66/13 65/14 70/9 63/16 264/52 28/12" 
Educ (yr) 10.8 _+ 2.9 11.2 ,+ 3.9 11.2 4- 3.4 11.0 -+ 3.2 11.1 ,+ 3.4 11.4- 4.2 
CVA/TIA 8 11 9 4 32 (10%) 3 (8%) 
DM 20 17 8 13 58 (18%) 5 (13%) 
MI <1/12 9 9 9 6 33 (10%) 0 
LVEF <50% 23 23 29 22 97 (31%) n/a 
LVEF <35% 5 6 4 2 17 (5%) n/a 
Prev CAB 4 9 8 7 28 (9%) 4 (10%) 
CAB, Coronary artery bypass study group; Cohort, noncardiac surgical control group; Educ (yr), years of education; CVA/TIA, history of cerebrovascular 
accident or transient ischemic attack; DM, diabetes mellitus; MI <1/12, myocardial infarction in previous month; LVEF <35%, patients with ventricular 
ejection fraction less than 35%; Prey CAB, previous coronary bypass urgery. 
*p = 0.036 versus CAB group. 
Table IV. Operative characteristics of CAB group 
Alpha-stat pH-stat 
Pulsatile Nonpulsatile Pulsatile Nonpulsatile CAB total 
(n=79)  (n=79)  (n=79)  (n=79)  (n=316)  
CAB >=4 10 16 22 17 65 (21%) 
AoXC (rnin) 43.9 ,+ 17 44.1 _+ 18 47.8 _+ 17 46.9 _+ 16 45.7 -+ 17 
CPB (min) 92.1 .+ 29 95.1 -+ 29 98.5 -+ 37 98.6 ,+ 33 96.1 + 32 
CPB > 90 (n) 41 46 42 45 174 
OR (rain) 271 -+ 48 280 -+ 76 279 _+ 59 282 -+ 57 278 ,+ 61 
PP (mm Hg) 17.1 -+ 6.0* 1.8 ,+ 2.4 15.9 ,+ 6.6* 1.5 -+ 2.2 NA 
MABP (mm Hg) 57.9 +- 12 61.0 -+ 11 57.2 .+ 10 57.6 _+ 12 58.4 -+ 12 
pHat  7.42 _+ 0.18§ 7.43 -- 0.12§ 7.26 _+ 0.13 7.26 -+ 0.06 NA 
pHa$ 7.43 -+ 0.06 7.43 -+ 0.06 7.43 .+ 0.05 7.43 _+ 0.05 7.43 ,+ 0.05 
Paco a (ram Hg)t  38.1 -+ 4.1§ 37.5 ,+ 4.1§ 57.5 _+ 6.9 59.3 .+ 6.4 NA 
Paco2 (mm Hg).~ 37.2 .+ 4.3 36.8 ,+ 4.9 38.5 -+ 4.5 40.6 -+ 6.5 38.3 ,+ 5.3 
NPT (° C) 28.5 ,+ 2.1 28.5 -+ 1.2 28.5 -+ 2.0 28.2 .+ 1.2 28.4 ,+ 1.7 
Hgb (gin/L) 78.4 -+ 18 78.9 -+ 12 81.5 .+ 15 78.4 -+ 12 79.3 ,+ 14 
Glu (mmol/dl) 10.6 -+ 3.5 11.3 + 3.0 10.4 _+ 3.1 10.4 ,+ 3.0 10.7 -+ 3.1 
Hosp (days) 13.4 -+ 11 12.2 -+ 5 14.8 -+ 25 12.9 -+ 11 13.3 -+ 15 
CAB >=4, Patients receiving four or more coronary bypass grafts; AoXC, aortic crossclamp time; CPB, duration of cardiopulmonary bypass; CPB > 90, 
number of patients undergoing prolonged CPB; OR, duration of surgery; PP, pulse pressure; MABP, mean arterial blood pressure; NPT, mean nasopharyngeal 
temperature during hypothermic CPB; Hgb, lowest mean hemoglobin concentration during hypothermic CPB; Glu, highest mean glucose values during 
hypothermic CPB; Hosp, surgery to discharge time with in-hospital deaths excluded; ?CA, Not available. 
*p < 0.001 versus nonpulsatile. 
tMean of all values measured at 37 ° C during hypotherrnic CPB. 
:~Mean of all values measured at 37 ° C during normothermic CPB. 
§p < 0.001 versus pH-stat. 
These four groups were therefore collapsed and 
analyzed according to either pulsatility or pH man- 
agement. Overall, there were no significant differ- 
ences in the incidences of either neurologic or 
cognitive dysfunction at 7 days or 2 months between 
patients in the pulsatile or the nonpulsatile groups 
or between alpha-stat and pH-stat groups (Table 
Vr). 
Duration of CPB had been identified at the 
inception of the study as one of the uncontrolled 
variables of interest. Moreover, past research has 
identified duration of CPB as a risk factor for 
negative CNS outcome. 3-5 In our study, longer du- 
ration of CPB was found to be associated with 
increased CNS dysfunction. Post-hoc analysis was 
therefore undertaken to examine whether potential 
cerebroprotective effects of a given perfusion tech- 
ni_que or pH management strategy would be most 
pronounced in those individuals undergoing CPB 
for a longer duration. Because mean duration of 
3 5 4 Murkin et al. 
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Table V. Neurologic and cognitive scores* by treatment group (mean + standard eviation) 
Baseline 
Neurologic Grooved Pegboard Digit Symbol Associate Learning 
seale~ Concentration¢ time (sec) raw score raw score§ 
Entire CAB group -1.4 +_ 1.4 0.00 -+ 0.86 89.4 _+ 21.0 37.7 -4- 10.0 22.7 + 6.5 
Alpha-stat group -1.4 +- 1.5 -0.07 ± 0.89 89.7 _+ 21.0 37.6 - 10.0 23.0 _+ 6.6 
pH-stat group -1.3 - 1.4 0.07 -+ 0.82 89.1 --- 21.0 37.8 -4- 10.1 22.4 -+ 6.3 
Pulsatile group -1.2 +_ 1.3 0.01 +_ 0.88 89.4 _+ 20.6 37.9 _+ 10.3 22.9 _+ 6.5 
Nonpulsatile group -1.6 + 1.5 -0.01 -+ 0.84 89.5 +- 21.4 37.4 +_ 9.7 22.5 - 6.4 
Alpha-stat/pulsatile group -1.2 -+ 1.2 -0.10 _+ 0.88 90.5 --- 21.6 37.7 _+ 10.4 23.6 -4- 6.9 
Alpha-stat/nonpulsatile group -1.7 _+ 1.6 -0.04 - 0.91 88.9 _+ 20.5 37.5 -+ 9.5 22.4 - 6.2 
pH-stat/pulsatile group -1.3 + 1.4 0.11 _+ 0.87 88.2 -+ 19.7 38.2 _+ 10.2 22.3 _+ 6.0 
pH-stat/nonpulsatile group -1.4 _+ 1.4 0.03 _+ 0.76 90.0 _+ 22.4 37.4 +- 10.0 22.5 --- 6.7 
Noncardiac surgical control group -1.7 _+ 1.5 0.00 --- 0.88 89.4 _+ 22.2 34.4 _+ 9.7 23.3 +- 5.7 
*For Grooved Pegboard time, higher scores reflect poor performance. For other measures, lower scores reflect poorer 
?Deficit from maximum attainable. 
:~Concentration score = (Mental Control Z-score + Digit Span Z-score)/2. 
§Associate Learning raw score = No. easy correct + 2(No. hard correct). 
IIDeficit from baseline. 
performance. 
CPB was approximately 90minutes, patients were 
arbitrarily grouped on the basis of CPB duration 
of less than or greater than 90 minutes, and 
neurologic and cognitive outcomes were analyzed 
according to CPB duration. The number of pa- 
tients included in the long CPB duration group 
(CPB > 90 minutes) did not differ across treat- 
ment groups (41 alpha/pulse; 46 alpha/nonpulse; 
42 pH/pulse; 45 pH/nonpulse; NS according to X 2 
test). Results of this post-hoe analysis revealed 
that for patients undergoing CPB of 90 minutes' 
duration or longer, the incidence of cognitive 
dysfunction was significantly (p = 0.047) lower at 
2 months (Table VII, Fig. 1) in the alpha-stat 
group than in the pH-stat group. 
Risk factors for dysfunction. Clinically relevant 
preoperative and intraoperative risk factors includ- 
ing age, weight, gender, presence of hypertension r
insulin-dependent diabetes mellitus, previous CVA 
or transient ischemic attack, carotid stenosis (lumi- 
nal narrowing >50%), duration of CPB, highest 
plasma glucose concentration during hypothermic or
normothermic CPB, weight, and presence of preoper- 
ative neuropathy were examined univariately todeter- 
mine significance of association with postoperative 
cognitive and neurologic dysfunction. Both neurologic 
and cognitive dysfunction at 7 days were found to be 
associated with CPB duration and age. At 2 months, 
neurologic dysfunction was related to history of hyper- 
tension, insulin-dependent diabetes mellitus, age, his- 
tory of CVA or transient ischemic attack, normother- 
mic glucose concentration, and carotid stenosis. 
Factors identified by univariate analysis as signif- 
icant, or as trending toward significance, were exam- 
ined multivariately in a stepwise fashion. For either 
cognitive or neurologic dysfunction, significant cor- 
relations with increased age (p = 0.0010), longer 
duration of CPB (p = 0.0053), increased weight (p = 
0.0065), and more years of education (p = 0.0017) 
were found at 7 days. At 2 months' follow-up, 
increased age (p = 0.0007) and presence of insulin- 
dependent diabetes mellitus (p = 0.0242) showed 
significant correlations with CNS dysfunction. 
Neurologic and cognitive dysfunction in CAB 
versus noncardiac surgical cohort. Seventy-three 
percent (29/40) of patients in the noncardiac surgi- 
cal cohort and 67% (211/316) of patients in the CAB 
group (p = NS) demonstrated preoperative neuro- 
logic abnormalities. In a younger group of 312 
patients undergoing CAB, Shaw and associates 3 
detected preoperative neurologic abnormalities in
over 35%, whereas Carella and colleagues 7 found 
preoperative n urologic signs in 57.5% of patients in 
the CAB group. At 7-day assessment the trend was 
toward a higher incidence of neurologic dysfunction 
(p = 0.085) and a significantly higher incidence of 
cognitive dysfunction (p = 0.003) and of either 
cognitive or neurologic dysfunction (p = 0.0002) in 
the CAB group compared with the noncardiac sur- 
gical cohort. At 2 months the incidence of neuro- 
logic dysfunction was higher in the CAB group (p = 
0.050), although the incidence of cognitive dysfunc- 
tion did not differ between groups. Overall results 
are shown in Table VIII and Fig. 2. 
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Seven day 
Neurologic Grooved Pegboard Digit Symbol Associate Learning 
scalell Concentration¢ time (sec) raw score raw score§ 
-2 .7  _+ 2.8 -0.17 _+ 0.91 102 -+ 31.7 34.7 _+ 11.0 20.5 -+ 6.6 
-3 .0 + 3.3 -0.21 + 0.95 101 _+ 31.9 35.1 _+ 11.0 20.7 + 7.5 
-2 .4 -+ 2.:2 -0.13 _+ 0.87 103 + 31.6 34.3 _+ 11.0 20.2 + 5.7 
-2.5 -+ 3.2 -0.21 _+ 0.94 103 _+ 35.1 34.8 + 11.3 20.3 + 6.5 
-2.8 -+ 2.5 -0.13 _+ 0.88 100 _+ 27.7 34.7 _+ 10.6 20.6 + 6.8 
-2 .7 -+ 3.!) -0.28 _+ 0.97 104 + 36.6 35.0 _+ 11.5 20.5 + 7.1 
-3 .2 -+ 2.6 -0.14 _+ 0.93 98.3 _+ 25.5 35.2 _+ 10.4 21.0 -+ 7.9 
-2.3 _+ 2.2 -0.13 +_ 0.91 103 + 33.7 34.6 _+ 11.2 20.0 + 6.0 
-2.5 _+ 2.2 -1.30 + 0.84 102 _+ 29.7 34.1 _+ 10.9 20.3 -+ 5.5 
-2 .2 + 1.6 0.06 _+ 0.82 93.0 4- 23.8 34.9 _+ 14.3 22.6 _+ 7.7 
Discussion 
Although the etiology of postoperative CNS dys- 
function is likely multifactorial, mierogaseous and 
particulate emboli are particularly culpable. 2z-a4 
Equipment modifications such as arterial ine filtra- 
tion and use of membrane versus bubble oxygen- 
ators can decrease mbolic load, 22' 23 although em- 
boli are not entirely eliminated. Duration of CPB, as 
shown here and previously, 3-s is an independent risk 
factor for postoperative neurologic and cognitive 
dysfunction. Therefore, the positive impact of pro- 
tective strategies would likely be most apparent in 
patients undergoing CPB of prolonged duration, 
who are exposed to a greater embolic load. Post-hoe 
subanalysis of the CAB study groups, as a function 
of duration of CPB with prolonged CPB defined as 
90 minutes or greater, demonstrated a lower inci- 
dence of cognitive dysfunction at 2 months for the 
group managed with alpha-stat pH management. 
pH management strategies. Alpha-stat manage- 
ment has been shown to preserve cerebral flow/ 
metabolism coupling such that hypothermia-in- 
duced decreases in metabolic rate are accompanied 
by proportionate decreases in cerebral blood 
flow.4, 10, 27 In contrast, the increased carbon di- 
oxide associated with pH-stat management induces 
cerebral vasodilatation and hyperemia resulting 
from pressure-passive changes in cerebral blood 
flOW.10-12, 17 The decreased incidence of cognitive 
dysfunction demonstrated 2 months after the oper- 
ation in the alpha-stat group undergoing prolonged 
CPB is consistent with the hypothesis that fewer 
emboli are delivered into the cerebral circulation 
because of the proportionate decrease in cerebral 
blood flow relative to that of the pH-stat group. 
In one of the few randomized studies of the 
influence of pH management s rategy on postoper- 
ative neuropsychologic functioning reported to date, 
86 patients with cardiac disease w re assessed, and 
no difference in incidence of postoperative cognitive 
dysfunction between alpha-stat and pH-stat man- 
agement was demonstrated, is In that study, how- 
ever, no stratification for duration of CPB was made 
when results were analyzed, patients undergoing 
both open and dosed chamber procedures were 
included, unfiltered bubble oxygenators were used, 
and pH-stat may not have been achieved in the 
treatment group. 25 Lack of a clear outcome benefit 
in those circumstances may reflect the effect of 
exposure to much greater numbers of emboli in 
comparison with patients in whom a filtered CPB 
circuit is used. 26 In addition, minimal differences in 
cerebral blood flow (and thus delivery of emboli nto 
cerebral circulation) may have been present be- 
tween their groups because of the small difference in 
actual arterial carbon dioxide tension (less than half 
that predicted)Y' 27 In contrast, a study of 65 pa- 
tients by Stephan and coworkers 17 demonstrated 
improved neurologic outcome with alpha-stat pH 
management. They used membrane oxygenators 
and arterial line filtration in patients undergoing 
CAB operations and performed a neurologic exam- 
ination before the operation and 7 days after the 
operation. Although cognitive testing was not per- 
formed on these patients, a higher incidence of 
neurologic dysfunction was found in patients in 
whom the pH-stat strategy (10/35) had been used 
than was found in those managed by the alpha-stat 
strategy (2/30). The 7% incidence of neurologic 
impairment reported in their alpha-stat group is 
lower than that which we observed (33%), however, 
and may reflect both differences in neurologic ex- 
amination technique and their use of a younger 
study population (mean age 56 years, eldest aged 68 
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Table V. Continued 
Follow-up 
Neurologic Grooved Pegboard Digit Symbol Associate Learning 
scale[l Concentrations time (sec ) raw score raw score# 
Entire CAB group -2.0 +- 2.2 0.12 + 0.86 83.5 --- 20.7 41.2 __. 12.1 24.1 - 7.0 
Alpha-stat group -2.1 _+ 2.2 0.13 _+ 0.85 82.3 -+ 19.0 41.1 _+ 11.1 24.0 -+ 7.3 
pH-stat group -1.8 + 2.2 0.11 _+ 0.88 84.8 _+ 22.3 41.2 ___ 13.1 24.2 + 6.8 
Pulsatile group -1.9 --- 2.1 0.09 ___ 0.89 85.0 --_ 23.8 41.0 _+ 13.1 24.4 -+ 7.2 
Nonpulsatile group -2.1 _+ 2.3 0.16 _+ 0.83 82.0 _+ 17.0 41.3 _+ 11.2 23.8 -+ 6.9 
Alpha-stat/pulsatile group -1.9 _+ 2.2 0.05 _+ 0.82 81.9 -4- 19.3 41.0 +_ 12.1 24.4 _+ 7.8 
Alpha-stat/nonpulsatile group -2.3 _+ 2.3 0.23 + 0.87 82.7 + 18.9 41.2 _+ 9.9 23.7 -+ 6.6 
pH-stat/pulsatile group -1.8 + 2.0 0.13 _+ 0.97 88.6 -+ 27.8 41.1 _+ 14.1 24.5 -+ 6.4 
pH-stat/nonpulsatile group -1.9 -+ 2.3 0.10 _+ 0.79 81.4 _+ 15.3 41.3 _+ 12.3 24.0 -4- 7.2 
Noncardiac surgical control group -1.8 -+ 1.7 0.23 + 0.84 82.7 --- 24.2 36.9 _ 10.8 25.5 -+ 7.0 
*For Grooved Pegboard time, higher scores reflect poor performance. For other measures, lower scores reflect poorer p rformance. 
,+Concentration score = (Mental Control Z-score + Digit Span Z-score)/2. 
§Associate Learning raw score = No. easy correct + 2(No. hard correct). 
IIDeficit from baseline. 
Table VI. Dysfunction by pH management and perfusion group 
Alpha-stat pH-stat Pulsatile Nonpulsatile 
Seven-day assessment 
Neuro 48/146 (33%) 40/143 (28%) 43/147 (29%) 45/142 (32%) 
Cognitive 106/136 (78%) 109/137 (80%) 111/140 (79%) 104/133 (78%) 
Either 117/142 (82%) 121/139 (87%) 119/142 (84%) 119/139 (86%) 
Two-month assessment 
Neuro 24/137 (18%) 23/139 (17%) 24/141 (17%) 23/135 (17%) 
Cognitive 36/119 (30%) 43/120 (36%) 38/120 (32%) 41/119 (34%) 
Either 53/125 (42%) 59/124 (48%) 56/126 (44%) 56/123 (46%) 
p = Not significant for all between-group comparisons. Neuro, Neurologic dysfunction; Either, dysfunction either cognitive or neurologic assessment. 
Table VII. Dysfunction by pH management group and CPB duration 
AIpha-stat pH-stat 
7 days 2 mo 7 days 2 mo 
CPB < 90 min 
Neuro 16/68 (24%) 9/62 (15%) 13/68 (19%) 11/60 (18%) 
Cognitive 48/66 (73%) 19/57 (33%) 48/66 (73%) 15/67 (26%) 
Either 51/66 (77%) 25/59 (42%) 52/66 (79%) 21/59 (36%) 
CPB >- 90 rain 
Neuro 32/78 (41%) 15/75 (20%) 27/75 (36%) 12/79 (15%) 
Cognitive 58/70 (83%) 17/62 (27%) 61/71 (86%) 28/63 (44%)* 
Either 66/76 (87%) 28/66 (42%) 69/73 (95%) 38/65 (58%)? 
Neuro, Neurologic dysfunction; Either, dysfunction 
*p = 0.047 versus alpha-stat. 
tp = 0.066 versus alpha-stat. 
 either cognitive or neurologic assessment. 
years). As demonstrated here and in other series, 
neurologic omplications rise disproportionately with 
increased age)' 2 Finally, Patel and colleagues TM used a 
standardized battery of 10 neuropsychologic tests be- 
fore the operation and 6 weeks after the operation in 
a series of 70 patients undergoing CAB and random- 
ized to alpha-stat or pH-stat strategies during nonpul- 
satile hypothermic CPB. They also demonstrated a 
significantly lower incidence of cognitive impairment 6 
weeks after the operation (20% versus 48.6%, respec- 
tively) in the patients in whom alpha-stat management 
was used, incidences similar to our results. 
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Fig. 1. Incidence of cognitive dysfunction 2 months after the operation for all patients in the CAB group 
and for those in whom CPB duration was 90 minutes or greater, excluding those in whom 7-day assessment 
was not available. 
Table VIII. Neurologic and cognitive dysfunction: CAB versus noncardiac surgical cohort 
CAB group Surgical cohort 
7 days 2 mo 7 days 2 mo 
Neuro 88/289 (30%)* 47/276 (17%)t 6/36 (17%) 1/30 (3%) 
Cognitive 215/273 (79%):~ 79/239 (33%) 19/34 (56%) 10/25 (40%) 
Either 238/281 (85%)§ 112/249 (45%) 20/34 (59%) 11/26 (42%) 
CAB group, Study group; Surgical cohort, noncardiac surgical ontrol group. Neuro, neurologic dysfunction; Either, dysfunction on either cognitive or 
neurologic assessment. 
*p = 0.085 versus surgical cohort. 
?p = 0.050 versus reference cohort. 
:~p = 0.003 versus surgical cohort. 
§p = 0.0002 versus surgical cohort. 
Perfusion techniques. Although by no means uni- 
versal, nonpulsatile perfusion has remained the 
most common mode of perfusion during CPB. In- 
creases in cerebral blood flow and improved cere- 
bral perfusion in the presence of cerebral isch- 
emia13, 28 were factors leading to our decision to test 
the CNS effects of pulsatile perfusion in the current 
study. No significant differences in neurologic or 
cognitive outcome were apparent with the use of 
pulsatile perfiJsion in this study, however, similar to 
what has been reported by Henze, Stephan, and 
SonntagJ 6This may reflect either that pulsatility is 
not important in influencing CNS outcome after 
CPB or that the characteristics of the pulsatile 
perfusion generated uring CPB are insufficient to 
significantly influence postoperative brain function. 
We did, however, observe a significantly lower mot- 
tality rate and lower incidences of cardiovascular 
complications in the pulsatile perfusion group (see 
part 1 of this study), 19 similar to the results reported 
by Taylor and associates. 29
Noncardiac surgical cohort. Although interest in 
neurologic dysfunction after CAB operations has 
been increasing, relatively few studies have incor- 
porated a noncardiac surgical cohort to help isolate 
risk factors associated with CPB, independent 
from that of undergoing a major surgical proce- 
dure. Shaw and colleagues 3 demonstrated an in- 
creased incidence and severity of postoperative 
cognitive dysfunction in patients having CAB com- 
pared with a reference cohort f 50 patients undergo- 
ing peripheral vascular surgery (79% versus 31%) 
when assessed before hospital discharge, similar to
our findings. The results of Smith 4 are also con- 
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Fig. 2. Percentage incidence of neurologic and cognitive dysfunction in CAB group and noncardiac 
surgical cohort 7 days and 2 months after the operation. 
sistent with our results in that at 8 days after the 
operation the incidence of moderate or severe 
cognitive deficit was significantly higher in a group 
of 67 patients having CAB, 73% versus 50%, respec- 
tively, than in a reference cohort of 24 patients 
having major vascular and non-CPB thoracic sur- 
gery. At 8 weeks after the operation, however, the 
incidences of neuropsychologic dysfunction were 
similar between groups at 37% and 44%, respec- 
tively. It was believed that different causes were 
involved in the genesis of impairment between the 
two groups, because patients in the reference cohort 
were older, had more extensive metabolic derange- 
ments (e.g., renal failure), and required more exten- 
sive pharmacologic support. Similarly, Hammeke 
and Hastings s reported that at 6 months postoper- 
atively, the incidence of cognitive dysfunction was 
comparable in both a group of 24 patients having 
CAB and a group of eight patients having peripheral 
vascular surgery; this study was criticized, however, 
because some of the tests used were not suitable 
for repeat assessments and because of the small 
number of patients available at follow-up. 3° We 
also found a significantly higher incidence of cogni- 
tive dysfunction at 7 days and no difference in i ci- 
dence of cognitive dysfunction at 2 months, but we did 
demonstrate a significantly higher incidence of post- 
operative neurologic dysfunction at 2 months (17% 
versus 3%), in comparison with a noncardiac surgical 
cohort. Notably, none of the aforementioned studies 
assessed postoperative n urologic function. 
The current results suggest that CAB operations 
are associated with a significantly greater incidence 
of cognitive dysfunction in the early postoperative 
period and a greater incidence of neurologic dys- 
function at follow-up than are operations in which 
CPB is not used. The high incidence of preoperative 
neurologic abnormalities detected in both the CAB 
and the surgical cohort, and the similar incidences of 
cognitive dysfunction in both groups at 2 months 
after the operation, also suggests that these patients 
may have a particular susceptibility o CNS dysfunc- 
tion because of associated isease processes (e.g., 
incipient cerebrovascular atherosclerosis). This sus- 
ceptibility may render them at greater isk from all 
procedures involved with major surgery (e.g., seda- 
tion/analgesics, intensive care management) rather 
than cardiac surgery exclusively. 
As proposed by Strittmatter and associates, 31 
patients with apolipoprotein E-e4 genotypes demon- 
strate impaired neuronal reparative processes and
are at increased risk of earlier onset of Alzheimer 
disease. These genotypes also appear to be at 
slightly increased risk of atherosclerosis and coro- 
nary artery disease 3a and thus may form a group that 
may be more susceptible to CNS injury. This is 
consistent with preliminary data from Tardiff and 
coworkers, 33 which demonstrated a correlation be- 
tween apolipoprotein E-e4 profile and cognitive 
dysfunction in patients undergoing CPB. 
Additionally, cognitive dysfunction at 2 months is 
less prevalent after 90 minutes of CPB in patients 
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managed with alpha-stat than with pH-stat strategy. 
This finding was obtained on a post-hoc analysis 
and, although consistent with findings of some prior 
research,~7, 18 it is subject to replication in future 
prospective studies. Finally, our results suggest hat 
both neurologic and cognitive measures contribute 
uniquely to estimates of post-CPB morbidity. Thus 
concomitant assessment of both parameters i  nec- 
essary to more fully quantify postoperative CNS 
dysfunction. 
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Appendix I (Western Perioperative Neurologic 
Scale--Guide) 
This scale is designed to detect and quantify anatomi- 
cally discrete neurologic abnormalities. It is not intended 
as an assessment of neurologic functioning. Test/re-test 
reliability of the neurologic examination was demon- 
strated by having the same examiner administering the 
same structured neurologic examination over a 7-day 
interval to a group of 28 patients convalescing in the 
hospital for more than 1 month after CVA (intraclass 
correlation coefficient = 0.986). 
Mentation 
Level of consciousness: Assessment ofpatient orientation, 
concentration, memory, andmental functioning. Orienta- 
tion is based on the patient's awareness of time, place, and 
person where person refers to the patient asable to give 
name and address, place to identify the city and or name 
of the hospital, and time where the patient must give at 
least the correct month and year. If early in the month 
(i.e., first 3 days) previous month is acceptable. Speech 
may be dysarthric (mispronounced or slurred) but intelli- 
gible. If for any reason the patient cannot answer specific 
questions on orientation (i.e., does not know the answer, 
gives the wrong answer, answers only partially, cannot 
express himself or herself either by lack of words or 
unintelligible speech or finally ignores questions), he or 
she is are considered isoriented. 
3. Normal: Normal consciousness, fully conscious. The 
patient is alert, attentive, aware, and appropriate. 
2. Drowsy: The patient when stimulated remains awake 
and alert for a short time but tends to doze off even 
during the examination. Lethargic but mentally intact. 
1. Stuporous: The patient is obtunded, responds to loud 
verbal stimuli and/or strong touch; may vocalize but 
does not become alert or completely awake. 
0. Comatose: The patient responds to deep pain such as 
sternal pressure, but (1) only by purposeful movement 
of a limb toward noxious stimuli and/or grimacing 
and/or moaning (no verbal response); (2) by nonpur- 
poseful movements, flexion of upper limbs (decortica- 
tion), or extension of upper limbs (i.e., decerebration); 
(3) no response to n xious stimuli. 
Speech. For the assessment of language/speech, either 
motor ability such as speaking or writing or sensory ability 
such as auditory or visual or mixed will be considered. 
Test for comprehension a d response ither verbally or 
nonverbally. 
3. Normal: The patient answers all commands and ques- 
tions, the conversation is fluent, and there is good 
comprehension of verbal language. If the patient is 
intubated, the patient can carry out a three-step com- 
mand. 
2. Dysphasia: The patient may have slurred speech (dys- 
arthria) but is still intelligible, is able to follow complex 
commands but may show hesitancy, may misspell words 
or make mistakes when reading aloud. The intubated 
patient can follow a two-step command or can be 
understood through writing or "reading lips." 
1. Aphasia: Expressive aphasia (Broca's) or receptive 
asphasia (Wernicke's). Broca's: Speech is halting or 
laborious, omitting connectives, able to comprehend 
and identify objects by name. Wemicke's: Speech is easy 
and fluent but with little or no meaning. Inappropriate 
words are juxtaposed with no insight and jargon is 
common. May neither understand nor follow com- 
mands or may be mute but comprehends. The patient 
is able to carry out a single-step command. 
0. Mute: Global aphasia. The patient is unable to com- 
prehend or follow command. 
Patients should always be scored according to their 
worst speech deficit (i.e., language score or mispronunci- 
ation). 
Memory. Testing to include short term and long term, 
may include digit span, recall, and the spelling of words 
backward. 
3. Normal: The patient is able to recall three words of 
three at 5 minutes. 
2. Mild deficit: The patient is able to recall two of the 
three words within 5 minutes or three of three with 
prompting. 
1. Moderate deficit: The patient is able to recall one word 
of three at 5 minutes or two of three with prompting. 
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0. Severe deficit: The patient is unable to recall any words 
of the three given even with prompting. 
Cranial nerves 
Vision. Assessment of visual acuity, visual fields, conju- 
gate and comrergence of pupils, ocular movements, and 
pupillary reaction. 
3. Normal: No visual loss, normal acuity with correction, 
normal visual fields (no change from the baseline). 
Normal extraocular movements, response to threat. 
2. Mild deficit: Inattention, partial palsy, partial field cut, 
a new diplopia, a change in extraocular movements. 
One modality not elicited (i.e., abnormal extraocular 
movement). 
1. Moderate deficit: Dense hemianopsia nd pupillary 
deviation, monocular hemianopsia. Two modalities ab- 
sent. 
0. Severe deficit: Functionally blind (i.e., the patient is 
able to see only large moving objects uch as a hand); 
the patient does not respond to testing. All modalities 
abnormal or absent. 
Cranial nerves. To assess the cranial nerves for facial 
motor function--V, VII, XII--as it pertains to the face, 
tongue movement, and airway protection. 
3. Normal: No weakness, facial symmetry. Normal gag 
reflex, tongue, and facial movement. 
2. Mild deficit: One of the areas show weakness, that is, 
facial asymmetry, poor airway protection. 
1. Moderate deficit: Two of the areas tested show weak- 
ness, that is, unilateral facial paralysis. 
0. Severe deficit: All of the areas tested show weakness, 
that is, dense facial palsy, loss of gag reflex, and unable 
to protect he airway. 
Motor. Testing of motor strength, both the upper and 
lower limbs, right and left sides. When strength or range 
of movement is being tested, the same resistance and 
position of pressure application must be submitted toeach 
limb. Motor fimction can be monitored by the ability of 
the patient to maintain a fixed posture in the upper or 
lower limb for 3 to 5 seconds; the observer will alternately 
place the limb in the desired position. 
UPPER LIMBS. Place the arms outstretched at 90 de- 
grees in front of the patient. Equal motor response: The 
patient can maintain the fixed posture equally in both 
upper limbs for a few seconds or withdraws equally on 
both sides to pain. Unequal motor response: The patient 
cannot maintain equally on both sides the fixed posture, 
weakness is noted on one side, or there is an unequal 
withdrawal to pain. Note side where the withdrawal is not 
as brisk. 
LOWER LIMBS. Flexion to thighs with knees flexed at 90 
degrees. Equal' motor esponse: The patient can maintain 
the fixed posture equally in both lower limbs for a few 
seconds or withdraws equally on both sides to pain. 
Unequal motor esponse: The patient cannot maintain the 
fixed posture equally on both sides, weakness i noted on 
one side, or there is an unequal withdraw to pain. Note 
side where the withdrawal is not as brisk. 
In the postoperative period, testing will be modified 
because of limitations of activity and accessory medical 
interventions such as intravenous lines and chest tubes. 
Test both upper and lower limbs, proximal and distal to 
flexion, extension and appropriate withdrawal. Test using 
either central stimuli (glabellar pressure) or peripheral 
stimuli (nailbed pressure) on the very drowsy patient. 
UPPER LIMB PROXIMAL. The patient should be tested 
while in the sitting position if possible. To test, abduct he 
arms to 90 degrees. If the patient is lying in bed, elevate 
arms to approximately 45 to 90 degrees. Test strength in
both arms simultaneously, resistance being applied to the 
midpoint between the shoulder and the elbow. 
UPPER LIMB DISTAL. The patient is tested in either lying 
or sitting position with the arms elevated. To test, the 
patient is asked to make a fist and to extend the wrists. A 
comparison range of movement in both wrists is made 
simultaneously. If the patient has full range of motion in 
both wrists, test strength byapplying resistance separately 
to both fists while stabilizing the arm firmly. Grip strength 
is also tested in both hands. 
LOWER L1MBS. The patient should be lying in the bed for 
all testing and scored on the worst deficit of either hip 
flexion or dorsiflexion. Hip flexion: Ask the patient o flex 
thighs toward the trunk with the knees flexed at 90 
degrees. Movement in both thighs is tested separately. 
Dorsiflexion: Have the patient point the toes and foot 
upward. Compare both feet simultaneously (i.e., complete 
or partial movement). In both cases apply resistance 
alternately to each thigh and foot after full movement has 
been completed to testing of strength. Dorsal extension: 
Have the patient extend the toes and foot downward and 
apply resistance. 
3. Normal: No detectable weakness. The patient is able to 
flex or extend the limb, appropriate withdrawal or 
localization. 
2. Mild weakness: Mild drift, apraxia, normal range of 
motion against gravity, but succumbs to resistance by 
observer either partially or totally. Also note the loss of 
rapid fine movements. Abnormal flexion of the extrem- 
ity. 
1. Moderate weakness: Gross drift. Cannot completely 
overcome gravity in the range of motion (i.e., partial 
movement). Abnormal extension of the extremity. 
0. Severe weakness: Paresis of limb or neglect. Absence 
of motion in movement tested or only contraction of 
muscles without actual movement of the limb. No 
motor response or flaccid. 
Sensation and cerebel lum 
Sensation. Testing of the right and left sides for light 
touch, temperature, vibration, and position sense. The 
right and the left sides should be assessed separately. 
3. Normal: No sensory deficit to any of the modalities 
tested. 
2. Mild deficit: Partial sensory or motor loss, tingling or 
numbness, inattention, loss of one modality. 
1. Moderate deficit: Unable to complete modality, loss of 
sensation of more than one modality. 
0. Severe deficit: Total sensory loss of all sensation, no 
response to painful stimuli. 
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Cerebellar. Testing includes finger-nose, heel-shin, and 
rapid tapping, nystagmus, ataxia, and incoordination. Pos- 
ture should be observed when the patient is sitting or 
standing. 
3. Normal: Intact 
2. Mild deficit: Loss of finger-nose, or heel-shin, or tap- 
ping: mild ataxia, involving only one limb. 
1. Moderate deficit: Loss of two of the modalities; gross 
ataxia. 
0. Severe deficit: Severe impairment of cerebellar func- 
tion to all modalities. 
Reflexes. The reflexes to be tested include jaw jerk, 
biceps, triceps, brachioradialis, knee, ankle, and plantar 
on both the right and the left sides. 
3. Normal: All reflexes are intact; toes downgoing. 
2. Mild deficit: One reflex is noted to be different in either 
the upper or lower limb (i.e., hyperreflexive arm or 
leg). 
1. Moderate deficit: Hyporeflexive or hyperreflexive side 
(i.e., arm and leg). 
0. Severe deficit: All reflexes abnormal (i.e., hyperactive 
in both arms and legs and bilateral upgoing toes) and 
clonus. 
Primitive reflexes. The primitive reflexes tested include 
grasp, palmomental, glabellar tap, sucking, and snout (pout). 
3. Absent: No primitive reflexes observed. 
2. One primitive reflex present. 
1. Two primitive reflexes present. 
0. All primitive reflexes present. 
Gait. Testing to include stance, gait, and Romberg. 
3. Normal: The gait is intact. 
2. Mild deficit: Wide-based stance, unsteady on feet, 
slight hemiparesis. 
1. Moderate deficit: Marked hemiparesis; the patient may 
be able to stand with assistance but would fall if not 
supported. 
0. Severe deficit: Unable to stand. 
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